Analysis of CAR-T cells that can persist for ten years in CLL patients revealed a predominant cytotoxic CD4+ T-cell population, raising the possibility that CD4+ T cells play important roles in durable T-cell therapy45. This evidence concerns the gene CD4 and B-cell chronic lymphocytic leukemia.